Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women
Description:
Safety and immunogenicity Phase II study in 270 healthy pregnant women in Denmark and United Kingdom. Study is conducted under an IND.
Status:
Study has completed enrolment and is ongoing
Countries:
UK and Denmark